The firm is accused of being late to reveal the risk the medication poses to pregnant women.
Amid the race to find a COVID-19 vaccine, the EU and governments are being called upon to guarantee that when one is ready it will be affordable and widely available.
Swiss drugmaker Novartis has launched an international lottery for its groundbreaking and extremely costly gene therapy Zolgensma, sparking both hope and outrage among patients’ families.
Servier Laboratories, the National Agency for the Safety of Medicines (ANSM) and 21 other defendants will face 2,684 plaintiffs. They allege that Mediator, marketed as an antidiabetic drug, has cost the lives of hundreds of patients.
Poland has won acclaim for its system to decide which medicines should be funded by taxpayers but still faces challenges in striking the right balance between expertise and transparency on healthcare policies.
The mysterious death of a pharmaceuticals billionaire and his wife in Toronto is now being investigated by homicide detectives.
The race to host the European medicines and banking agencies after Brexit was so tight that the winners were ultimately drawn from a bowl.
US health giant sued in Australia in a class action case by more than 700 women